Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
BioSyent Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2028 | $89.90M | $89.90M - $89.90M | $25.80M | $1.26 | 1 |
| Dec 2027 | $82.30M | $82.30M - $82.30M | $23.62M | $1.08 | 1 |
| Dec 2026 | $69.00M | $69.00M - $69.00M | $19.81M | $0.89 | 1 |
| Dec 2025 | $43.60M | $43.60M - $43.60M | $12.51M | $0.79 | 1 |
| Dec 2024 | $35.40M | $35.40M - $35.40M | $10.16M | $0.63 | 1 |
| Dec 2023 | $32.10M | $31.84M - $32.36M | $8.99M | $0.58 | 1 |
| Dec 2022 | $27.40M | $26.75M - $28.05M | $7.68M | $0.43 | 1 |
| Dec 2021 | $28.10M | $28.10M - $28.10M | $7.87M | $0.41 | 1 |
| Dec 2020 | $22.05M | $22.05M - $22.05M | $6.18M | $0.30 | 1 |
| Dec 2019 | $21.50M | $21.50M - $21.50M | $6.02M | $0.31 | 1 |
| Dec 2018 | $21.76M | $21.76M - $21.76M | $6.10M | $0.383 | 1 |
| Dec 2017 | $20.70M | $20.70M - $20.70M | $5.80M | $0.36 | 1 |